Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review.

ABSTRACT:

Background

Diabetic retinopathy (DR) is a significant global public health and economic burden. DR accounts for approximately 15-17% of all cases of total blindness in the USA and Europe. Telemedicine is a new intervention for DR screening, however, there is not enough evidence to support its cost-effectiveness. The aim of this study is to review the most recent published literature on economic evaluations of telemedicine in DR screening and summarize the evidence on the cost-effectiveness of this technology.

Methods

A systematic search of PubMed, Embase and Google Scholar for relevant articles published between January 2010 and January 2020. Studies were included if they met the following criteria: (1) recruited subjects with either type 1, type 2 diabetes (2) evaluated tel

SUBMITTER: Avidor D 

PROVIDER: S-EPMC7137317 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature